Merimsky O - Search Results

1

Metastases to the retroperitoneum in patients with extremity soft tissue sarcoma: an unusual metastatic pattern.

Lev-Chelouche D, Nakache R, Soffer D, Merimsky O, Klausner MJ, Gutman M. Lev-Chelouche D, et al. Among authors: merimsky o. Cancer. 2000 Jan 15;88(2):364-8. doi: 10.1002/(sici)1097-0142(20000115)88:2<364::aid-cncr17>3.0.co;2-w. Cancer. 2000. PMID: 10640969

2

Serial serum MCA measurements in the follow-up of breast cancer patients.

Merimsky O, Inbar M, Hareuveni M, Witenberg B, Wolman Y, Chaitchik S. Merimsky O, et al. Eur J Cancer. 1991;27(11):1440-4. doi: 10.1016/0277-5379(91)90027-b. Eur J Cancer. 1991. PMID: 1835861

3

A phase II trial of D-Trp-6-LHRH (decapeptyl) in pretreated patients with advanced epithelial ovarian cancer.

Ron IG, Wigler N, Merimsky O, Inbar MJ, Chaitchik S. Ron IG, et al. Among authors: merimsky o. Cancer Invest. 1995;13(3):272-5. doi: 10.3109/07357909509094461. Cancer Invest. 1995. PMID: 7743379 Clinical Trial.

4

Treatment of disease-negative but mucin-like carcinoma-associated antigen-positive breast cancer patients with tamoxifen: preliminary results of a prospective controlled randomized trial.

Kovner F, Merimsky O, Hareuveni M, Wigler N, Chaitchik S. Kovner F, et al. Among authors: merimsky o. Cancer Chemother Pharmacol. 1994;35(1):80-3. doi: 10.1007/BF00686288. Cancer Chemother Pharmacol. 1994. PMID: 7987981 Clinical Trial.

5

Recombinant interferon alpha-2a in combination with dacarbazine in the treatment of metastatic malignant melanoma: analysis of long-term responding patients.

Ron IG, Inbar MJ, Gutman M, Merimsky O, Chaitchik S. Ron IG, et al. Among authors: merimsky o. Cancer Immunol Immunother. 1993 Jul;37(1):61-6. doi: 10.1007/BF01516943. Cancer Immunol Immunother. 1993. PMID: 8513453 Free PMC article. Clinical Trial.

6

Malignant melanoma of the head and neck. Clinical and immunological considerations.

Merimsky O, Fishman P, Feldman I, Shafir R, Rapaport Y, Sheonfeld Y, Chaitchik S. Merimsky O, et al. Am J Clin Oncol. 1996 Aug;19(4):363-7. doi: 10.1097/00000421-199608000-00008. Am J Clin Oncol. 1996. PMID: 8677905

7

Failure of thalidomide to inhibit tumor growth and angiogenesis in vivo.

Gutman M, Szold A, Ravid A, Lazauskas T, Merimsky O, Klausner JM. Gutman M, et al. Among authors: merimsky o. Anticancer Res. 1996 Nov-Dec;16(6B):3673-7. Anticancer Res. 1996. PMID: 9042240

8

Vascular invasion in high grade sarcoma of the extremity is associated with short overall survival.

Merimsky O, Isakov J, Kollender Y, Nirkin A, Inbar M, Meller I. Merimsky O, et al. Oncol Rep. 1998 Jul-Aug;5(4):985-9. doi: 10.3892/or.5.4.985. Oncol Rep. 1998. PMID: 9625859

9

Synergism of tumor necrosis factor-alpha and melphalan in systemic and regional administration: animal study.

Gutman M, Sofer D, Lev-Chelouche D, Merimsky O, Klausner JM. Gutman M, et al. Among authors: merimsky o. Invasion Metastasis. 1997;17(4):169-75. Invasion Metastasis. 1997. PMID: 9778589

10

Isolated limb perfusion with high-dose tumor necrosis factor alpha and melphalan for Kaposi sarcoma.

Lev-Chelouche D, Abu-Abeid S, Merimsky O, Isakov J, Kollander Y, Meller I, Klausner JM, Gutman M. Lev-Chelouche D, et al. Among authors: merimsky o. Arch Surg. 1999 Feb;134(2):177-80. doi: 10.1001/archsurg.134.2.177. Arch Surg. 1999. PMID: 10025459 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

226 results

Search Page

Filters